The Role of CAS 1998-66-9 in Modern Drug Discovery
In the relentless pursuit of new therapeutic solutions, the pharmaceutical industry relies heavily on specialized chemical building blocks. Among these, 4-Bromo-2,3,5,6-tetrafluoroaniline, identified by its CAS number 1998-66-9, stands out as a pivotal intermediate. Its unique chemical properties make it indispensable for researchers and manufacturers aiming to synthesize novel drug candidates with enhanced efficacy and safety profiles.
Why is CAS 1998-66-9 a Key Player in Drug Discovery?
The presence of multiple fluorine atoms and a bromine atom on the aniline ring of 4-Bromo-2,3,5,6-tetrafluoroaniline confers distinct electronic and steric properties. These attributes are crucial for several reasons:
- Enhanced Bioavailability and Metabolism: Fluorine substitution can significantly alter a molecule's lipophilicity, metabolic stability, and binding affinity to biological targets. This often translates to improved pharmacokinetic properties and therapeutic outcomes for the resulting drug.
- Unique Reactivity: The compound is known for its ability to undergo reactions that lead to aryl radical formation, a powerful tool in modern synthetic chemistry for creating complex carbon-carbon and carbon-heteroatom bonds. This reactivity is vital for constructing the intricate scaffolds of many advanced pharmaceuticals.
- Building Block for Diverse Therapeutics: Researchers utilize this intermediate in the synthesis of various drug classes, including those targeting inflammation, infectious diseases, and oncological conditions. Its versatility allows for the creation of a broad spectrum of potential APIs.
Navigating the Procurement of CAS 1998-66-9
For pharmaceutical companies and contract research organizations (CROs), securing a consistent and high-quality supply of CAS 1998-66-9 is paramount. When considering a purchase, it's advisable to:
- Prioritize Purity: Pharmaceutical-grade intermediates require exceptionally high purity to ensure the integrity and safety of the final drug product. Verify that the supplier can provide documentation, such as a Certificate of Analysis (COA), confirming ≥99% purity.
- Look for Reliable Suppliers: Establishing a relationship with a trusted manufacturer, especially one with significant experience in producing fluorinated intermediates, is crucial. Suppliers in China are often well-equipped for large-scale production and competitive pricing.
- Evaluate Lead Times and Scalability: Understand the supplier's production capacity and lead times to ensure they can meet both R&D and potential commercial-scale demands.
- Request Samples for Testing: Before committing to large orders, always request samples to conduct in-house quality assessments and compatibility testing.
NINGBO INNO PHARMCHEM CO.,LTD. is a recognized manufacturer and supplier specializing in high-purity pharmaceutical intermediates. We are committed to providing CAS 1998-66-9 with the stringent quality and reliability that the pharmaceutical industry demands. Our robust manufacturing processes and quality assurance systems are designed to support your drug discovery and development efforts. Contact us today to discuss your specific requirements and obtain a quote for this essential building block.
Perspectives & Insights
Core Pioneer 24
“Unique Reactivity: The compound is known for its ability to undergo reactions that lead to aryl radical formation, a powerful tool in modern synthetic chemistry for creating complex carbon-carbon and carbon-heteroatom bonds.”
Silicon Explorer X
“This reactivity is vital for constructing the intricate scaffolds of many advanced pharmaceuticals.”
Quantum Catalyst AI
“Building Block for Diverse Therapeutics: Researchers utilize this intermediate in the synthesis of various drug classes, including those targeting inflammation, infectious diseases, and oncological conditions.”